309 related articles for article (PubMed ID: 25597318)
1. [Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy].
Simonyi G; Ferenci T
Orv Hetil; 2015 Jan; 156(4):141-5. PubMed ID: 25597318
[TBL] [Abstract][Full Text] [Related]
2. [Medication adherence with the fixed combination of ramipril and amlodipine].
Simonyi G; Ferenci T
Orv Hetil; 2014 Nov; 155(47):1882-8. PubMed ID: 25403283
[TBL] [Abstract][Full Text] [Related]
3. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
4. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
[TBL] [Abstract][Full Text] [Related]
5. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].
Simonyi G; Ferenci T
Orv Hetil; 2016 Mar; 157(11):425-9. PubMed ID: 26947091
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
[TBL] [Abstract][Full Text] [Related]
7. Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.
Averna M; Missault L; Vaverkova H; Farnier M; Viigimaa M; Dong Q; Shah A; Johnson-Levonas AO; Taggart W; Brudi P
Diab Vasc Dis Res; 2011 Oct; 8(4):262-70. PubMed ID: 21859750
[TBL] [Abstract][Full Text] [Related]
8. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
[TBL] [Abstract][Full Text] [Related]
9. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
Catapano A; Brady WE; King TR; Palmisano J
Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP; Blazing MA; Giugliano RP; McCagg A; White JA; Theroux P; Darius H; Lewis BS; Ophuis TO; Jukema JW; De Ferrari GM; Ruzyllo W; De Lucca P; Im K; Bohula EA; Reist C; Wiviott SD; Tershakovec AM; Musliner TA; Braunwald E; Califf RM;
N Engl J Med; 2015 Jun; 372(25):2387-97. PubMed ID: 26039521
[TBL] [Abstract][Full Text] [Related]
11. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
Simonyi G; Ferenci T
Orv Hetil; 2016 Jan; 157(1):30-4. PubMed ID: 26708684
[TBL] [Abstract][Full Text] [Related]
12. [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].
Namal E; Sener N; Ulaş T; Akçalı Z; Oztekin E; Borlu F
Anadolu Kardiyol Derg; 2011 Dec; 11(8):703-10. PubMed ID: 22088858
[TBL] [Abstract][Full Text] [Related]
13. The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
Efrati S; Averbukh M; Dishy V; Faygenzo M; Friedensohn L; Golik A
Eur J Clin Pharmacol; 2007 Feb; 63(2):113-21. PubMed ID: 17200833
[TBL] [Abstract][Full Text] [Related]
14. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
Scheen AJ; Radermecker RP
Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
[TBL] [Abstract][Full Text] [Related]
16. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
18. [One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination].
Simonyi G; Ferenci T
Orv Hetil; 2016 Apr; 157(16):618-22. PubMed ID: 27063429
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering study raises issues of therapy's value.
Thompson CA
Am J Health Syst Pharm; 2008 Apr; 65(7):594-5. PubMed ID: 18359962
[No Abstract] [Full Text] [Related]
20. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Robinson JG; Davidson MH
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
